Benitec Biopharma Limited

The momentum for this stock is not very good. Benitec Biopharma Limited is not very popular among insiders. Tradey thinks it is not wise to invest in Benitec Biopharma Limited.
Log in to see more information.
Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It...

News

Benitec Biopharma Inc. (NASDAQ:BNTC) Shares Purchased by GAMMA Investing LLC
Benitec Biopharma Inc. (NASDAQ:BNTC) Shares Purchased by GAMMA Investing LLC

Ticker Report GAMMA Investing LLC increased its position in shares of Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) by 53.0% in the 2nd quarter, according to the company in its most recent disclosure with the...\n more…

GAMMA Investing LLC Has $38,000 Stock Position in Benitec Biopharma Inc. (NASDAQ:BNTC)
GAMMA Investing LLC Has $38,000 Stock Position in Benitec Biopharma Inc. (NASDAQ:BNTC)

Zolmax GAMMA Investing LLC raised its stake in Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) by 53.0% during the second quarter, according to its most recent Form 13F filing with the Securities and...\n more…

Equities Analysts Set Expectations for Benitec Biopharma Inc.'s FY2024 Earnings (NASDAQ:BNTC)
Equities Analysts Set Expectations for Benitec Biopharma Inc.'s FY2024 Earnings (NASDAQ:BNTC)

Zolmax Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) - Equities researchers at Leerink Partnrs issued their FY2024 earnings estimates for Benitec Biopharma in a research report issued on Monday...\n more…

Benitec Biopharma (NASDAQ:BNTC) Now Covered by Analysts at SVB Leerink
Benitec Biopharma (NASDAQ:BNTC) Now Covered by Analysts at SVB Leerink

Zolmax Research analysts at SVB Leerink initiated coverage on shares of Benitec Biopharma (NASDAQ:BNTC - Get Free Report) in a report released on Monday, Briefing.com reports. The firm set an "outperform...\n more…

Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for Firs
Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for Firs

Globe Newswire -The post-dose average values for Total Pharyngeal Residue (i.e., the amount of solid food or liquid material remaining in the pharynx after the first swallow) remained meaningfully reduced at the...\n more…

Benitec Biopharma Inc. (NASDAQ:BNTC) Sees Large Growth in Short Interest
Benitec Biopharma Inc. (NASDAQ:BNTC) Sees Large Growth in Short Interest

Ticker Report Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling...\n more…